Sensor-enabled rubber ducks might be the solution to keeping track of major weather events. Courtesy of Project Owl

Nearly two years after Hurricane Harvey battered the Houston area, a flock of electronic "rubber ducks" flew above homes in Katy in a broader endeavor to keep first responders and victims connected during natural disasters.

Developers and backers of Project Owl, an Internet of Things (IoT) hardware and software combination, conducted a pilot test of this innovation June 1 — the first day of this year's hurricane season. In the Katy test, 36 "ducks" took flight.

Bryan Knouse, co-founder and CEO of Project Owl (organization, whereabouts, and logistics), says the initiative marries:

  • A deployable IoT network of DuckLink devices that can quickly provide a basic WiFi setup where communications infrastructure might be down, like a region where a hurricane just hit. A single device can connect through WiFi to smartphones and laptops.
  • A software data visualization platform that speeds up and simplifies data monitoring on the Clusterduck network.

"So, our technology can be deployed to help communities that have been destroyed after natural disasters by providing quickly accessible communications network to coordinate and organize a response," Knouse tells InnovationMap.

The DuckLink network comprises hubs resembling rubber ducks, which can float in flooded areas if needed. It takes only five of these hubs to cover one square mile. This network sends speech-based communications using conversational systems (like Alexa and Facebook Messenger) to a central application. The app, the Owl software incident management system, relies on predictive analytics and various data sources to build a dashboard for first responders.

"Once this network of ducks is deployed and then clustered, civilians are able to basically get on the devices through a really intuitive interface and contact first responders with a list of things that are really essential to them," Project Owl team member Magus Pereira explained in an October 2018 blog post.

Project Owl, which won IBM's Call for Code Global Challenge in 2018, is being developed by Code and Response, an IBM program that puts open source technologies in communities that most need them. Knouse and Houston software engineer Charlie Evans lead Project Owl.

In a June 6 blog post, Evans recalled the widespread damage his hometown suffered during Hurricane Harvey and stressed the importance of efforts like Project Owl.

"The sheer magnitude of storms like this," Evans writes of Hurricane Harvey, "and the fact that extreme weather isn't going anywhere anytime soon, really drive home the point that effective communication and logistics are among the highest [priorities] for organizations that are involved with rescuing people and with cleanup."

Katy was the second pilot site for Project Owl. The first large-scale test was done in March in Puerto Rico.

Members of the Project Owl team were pleased with the Katy test. Knouse says the speed of DuckLink deployment improved versus the Puerto Rico test, and the network error transmission rate fell from more than 30 percent to around 10 percent.

"This test is important for anyone who wants to see how we will support communities during natural disasters," Knouse tells InnovationMap. "The growth and improvement [seen in the Katy test] confirms that we can continue to improve the speed, scale, and performance of the network, elevating confidence that if it's deployed during a real disaster, we can support recovery and critical life saving activities."

Following the Puerto Rico and Katy pilots, Project Owl will test the technology again later this year in Puerto Rico, as well as in Alabama, California, and Washington state, according to Knouse.

"It's one thing to build something in a lab and say, 'It works.' It's another to have complete strangers watch the technology deployment and say, 'It works — we need this as soon as possible.' And we are working at maximum capacity to make that happen," Knouse wrote in May.

Owl deploys duck technology

Courtesy of Project Owl

About five of the "rubber ducks" are needed to track one square mile.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston space company lands latest NASA deal to advance lunar logistics

To The Moon

Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

“Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

“We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.